When was Chr. Olesen Synthesis founded?

Chr. Olesen Synthesis was founded in 2011.

Where is Chr. Olesen Synthesis located?

Chr. Olesen Synthesis is headquartered in Hvidovre, Denmark. It is registered at 8, Kanalholmen, Hvidovre, 2650.

Where does Chr. Olesen Synthesis rank among its competitors?

Chr. Olesen Synthesis ranks 1365th amongst 2326 active competitors, of which 73 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Chemours, which secured $375K in Nov, 2025.

Who are the top competitors of Chr. Olesen Synthesis?

Chr. Olesen Synthesis' top competitors include Corbion, Chemours and AGC. Among them, Chemours secured the most recent funding round in November, 2025.

Chr. Olesen Synthesis - 2026 Company Profile & Competitors

Company Details

Manufacturer of APIs and advanced intermediates, offering a range of products and expertise in the field of pharmaceuticals. The company specializes in the development and production of complex molecules, with a focus on quality and customer satisfaction. With a strong track record of innovation and collaboration, Chr. Olesen Synthesis is well-positioned to meet the evolving needs of the pharmaceutical industry.

Website: cosynthesis.dk
Registered Address: 8, Kanalholmen, Hvidovre, 2650

Key Metrics

Founded Year

2011

Location

Hvidovre, Denmark

Stage

Acquired

Ranked

1365^th among 2326 active competitors

Similar Companies

Corbion & 2404 more

Exit Details

Acquired

View Chr. Olesen Synthesis' full profile

Chr. Olesen Synthesis is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CHR. OLESEN SYNTHESIS A/S CIN: 33964870 , Denmark, Active	Oct 16, 2011	-	-

Chr. Olesen Synthesis got acquired on Oct 02, 2026.

Click here to take a look at Chr. Olesen Synthesis's acquisition in detail

Chr. Olesen Synthesis has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Chr. Olesen Synthesis include Corbion, Chemours and AGC. Here is the list of Top 10 competitors of Chr. Olesen Synthesis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Corbion 1919, Amsterdam (Netherlands), Public	Manufacturer of food ingredients, biochemicals, biomedical polymers, and algae-based products	-	The Roda Group, Triodos Investment Management ... & 5 others	68/100
2nd	Chemours 2015, Wilmington (United States), Public	Chemical corporation	-	Soor Capital, OSTI & 1 others	65/100
3rd	AGC 2000, Tokyo (Japan), Public	Manufacturers of glass, chemicals, and ceramics	-	Economy And Finance, Europa	65/100
4th	DFPCL 1979, Pune (India), Public	Manufacturer of fertilizers, industrial chemicals, and value-added real estate	-	Fidelity Investments, Axis Mutual Fund & 5 others	64/100
5th	Air Liquide 1902, Paris (France), Public	Supplier of gases & chemical products	-	Societe Generale, Federalministryforeconomicaffairsandenergy ... & 4 others	64/100
6th	Lgchem 1947, South Korea, Public	Manufacturer of petrochemicals, advanced materials, and innovative life science solutions	-	Gates, European Investment Bank	63/100
7th	Hexion Columbus (United States), Acquired	Manufacturer of resins and chemical additives for industrial production processes	$15.3M	Europa	61/100
8th	Grasim Mumbai (India), Public	Manufacturer of fabrics and synthetic yarn products	-	-	61/100
9th	Solvay 1863, Belgium, Public	Manufacturer of inorganic chemicals and advanced materials	-	GrandEst, BAFA & 8 others	61/100
10th	Johnson Matthey 1817, London (United Kingdom), Acquired	Manufacturer of platinum group metal catalysts and chemical process technologies	-	DOE, Appy Ventures & 2 others	61/100
1365th	Chr. Olesen Synthesis 2011, Hvidovre (Denmark), Acquired	Manufacturer of APIs and advanced intermediates, offering expertise in synthesis, production, and delivery of high-quality compounds for various industries	-	-	25/100